{"id":5472,"date":"2016-07-02T19:49:02","date_gmt":"2016-07-03T00:49:02","guid":{"rendered":"https:\/\/omcabogados.com.pe\/?p=5472"},"modified":"2025-08-12T11:11:28","modified_gmt":"2025-08-12T16:11:28","slug":"las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru","status":"publish","type":"post","link":"https:\/\/omcabogados.com.pe\/zh\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/","title":{"rendered":"\u4e8c\u6b21\u4f7f\u7528\u4e13\u5229\uff1a\u79d8\u9c81\u7684\u4f1f\u54e5\u6848\u4f8b"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"5472\" class=\"elementor elementor-5472\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-43df059 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"43df059\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-1c75cc0\" data-id=\"1c75cc0\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0ba0e4e elementor-widget elementor-widget-text-editor\" data-id=\"0ba0e4e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><strong>1.\t\u80cc\u666f\uff1a <\/strong><\/p><p>En Mayo de 1994, Pfizer solicit\u00f3 para uso m\u00e9dico la patente denominada \u201cPirazolopirimidinona para el tratamiento de la impotencia\u00bb, m\u00e1s conocida como Viagra, cuyo compuesto qu\u00edmico el \u201ccitrato de sildenafil\u201d ya era usado para el tratamiento de enfermedades cardiovasculares. La solicitud hab\u00eda sido rechazada hasta en 3 ocasiones anteriores por la Oficina de Invenciones y Nuevas Tecnolog\u00edas del Instituto Nacional de Defensa de la Competencia y de la Protecci\u00f3n de la Propiedad Intelectual (en adelante INDECOPI) del Per\u00fa, al contravenir lo se\u00f1alado en el Art\u00edculo 16 de la Decisi\u00f3n 344, y el Art\u00edculo 43 del Decreto Legislativo No.823, vigentes en ese momento, los cuales se\u00f1alan que los productos y procedimientos ya patentados \u201cno ser\u00e1n objeto de nueva patente, por el simple hecho de atribuirse un uso distinto al originalmente comprendido por la patente inicial.\u201d<\/p><p>\u7136\u800c\uff0c1997\u5e746\u6708\uff0c\u53d1\u5e03\u4e86\u7b2c010-97\/ITINCI\u53f7\u6700\u9ad8\u6cd5\u4ee4\uff0c\u4ee5\u201c\u6f84\u6e05\u548c\u89e3\u91ca\u7b2c344\u53f7\u51b3\u7b56\u7684\u82e5\u5e72\u6761\u6b3e\u201d\uff0c\u5305\u62ec\u7b2c16\u6761\u3002\u8be5\u6700\u9ad8\u6cd5\u4ee4\u7279\u522b\u662f\u5728\u7b2c4\u6761\u89c4\u5b9a\uff0c\u201c\u82e5\u6280\u672f\u72b6\u6001\u4e2d\u5305\u542b\u7684\u4e0d\u540c\u7528\u9014\u7b26\u5408\u7b2c823\u53f7\u7acb\u6cd5\u6cd5\u4ee4\u7b2c22\u6761\u7684\u8981\u6c42\uff08\u5373\u4f20\u7edf\u7684\u521b\u65b0\u6027\u3001\u65b0\u9896\u6027\u548c\u5de5\u4e1a\u9002\u7528\u6027\u8981\u6c42\uff09\uff0c\u5219\u53ef\u4ee5\u7533\u8bf7\u65b0\u7684\u4e13\u5229\u201d\uff0c\u56e0\u6b64\uff0cINDECOPI\u53d1\u660e\u4e0e\u65b0\u6280\u672f\u529e\u516c\u5ba4\u4e8e1999\u5e741\u670829\u65e5\u901a\u8fc7050-1999\/OIN-INDECOPI\u53f7\u51b3\u8bae\uff0c\u6388\u4e88\u8f89\u745e\u516c\u53f8\u4f1f\u54e5\u4e13\u5229\u3002<\/p><p>\u4e0e\u6b64\u540c\u65f6\uff0c\u4e00\u4e9b\u79d8\u9c81\u5b9e\u9a8c\u5ba4\u5df2\u5f00\u59cb\u751f\u4ea7\u4f1f\u54e5\u7684\u4eff\u5236\u836f\uff0c\u8ba4\u4e3a\u8f89\u745e\u7684\u4e13\u5229\u7533\u8bf7\u4f1a\u88ab\u62d2\u7edd\u3002\u8f89\u745e\u5a01\u80c1\u5c06\u4ee5\u5176\u65b0\u83b7\u5f97\u7684\u4e13\u5229\u4e3a\u57fa\u7840\u8d77\u8bc9\u5b83\u4eec\uff0c\u8fd9\u5bfc\u81f4\u79d8\u9c81\u56fd\u5185\u7684\u56fd\u5bb6\u8d44\u672c\u6765\u6e90\u5236\u836f\u5de5\u4e1a\u534f\u4f1a\uff08ADIFAN\uff09\u5411\u5b89\u7b2c\u65af\u5171\u540c\u4f53\u79d8\u4e66\u5904\u6295\u8bc9\uff0c\u79f0\u8f89\u745e\u8fdd\u53cd\u4e86\u7b2c344\u53f7\u51b3\u7b56\u7b2c16\u6761\u3002<\/p><p>2000\u5e7410\u670812\u65e5\uff0c\u6839\u636e\u5b89\u7b2c\u65af\u5171\u540c\u4f53\u6cd5\u9662\u521b\u5efa\u6761\u7ea6\u7b2c29\u6761\uff0c\u8be5\u6761\u8d4b\u4e88\u201c\u8be5\u6cd5\u9662\u901a\u8fc7\u9884\u5224\u65b9\u5f0f\u89e3\u91ca\u5171\u540c\u4f53\u6cd5\u5f8b\u79e9\u5e8f\u4e2d\u7684\u89c4\u8303\uff0c\u786e\u4fdd\u5176\u5728\u6210\u5458\u56fd\u9886\u571f\u4e0a\u7684\u5e94\u7528\u201d\u7684\u6743\u529b\uff0c\u5b89\u7b2c\u65af\u5171\u540c\u4f53\u79d8\u4e66\u5904\u9488\u5bf9\u79d8\u9c81\u5171\u548c\u56fd\u63d0\u8d77\u8fdd\u7ea6\u8bc9\u8bbc\uff08\u6848\u4ef689-AI-2000\uff09\uff0c\u6307\u63a7\u79d8\u9c81\u6388\u4e88\u201c\u7528\u4e8e\u6cbb\u7597\u9633\u75ff\u7684\u5421\u5511\u5627\u5576\u916e\u201d\u7b2c\u4e8c\u7528\u9014\u4e13\u5229\uff0c\u800c\u5171\u540c\u4f53\u6cd5\u89c4\u660e\u786e\u7981\u6b62\u5bf9\u7b2c\u4e8c\u7528\u9014\u6216\u4e0d\u540c\u7528\u9014\u8fdb\u884c\u4e13\u5229\u7533\u8bf7\u3002<\/p><p>\u5728\u5b89\u7b2c\u65af\u6cd5\u89c4\u6267\u884c\u673a\u5236\u7684\u591a\u6b21\u538b\u529b\u4e0b\uff0c\u4ee5\u53ca\u7531\u4e8e\u8be5\u8fdd\u7ea6\u8bc9\u8bbc\uff0c\u79d8\u9c81\u653f\u5e9c\u901a\u8fc7\u5176\u4e3b\u7ba1\u673a\u6784INDECOPI\uff0c\u6839\u636e2002\u5e748\u670827\u65e5\u53d1\u5e03\u7684000955-2002\/ONI-INDECOPI\u53f7\u51b3\u8bae\uff0c\u5ba3\u5e03\u8f89\u745e\u7814\u7a76\u4e0e\u5f00\u53d1\u516c\u53f8\uff08Pfizer Research and Development Company N.V.\/S.A.\uff09\u540d\u4e0b\u7684\u201c\u7528\u4e8e\u6cbb\u7597\u9633\u75ff\u7684\u5421\u5511\u5627\u5576\u916e\u201d\u7b2c\u4e8c\u7528\u9014\u53d1\u660e\u4e13\u5229\u65e0\u6548\uff0c\u539f\u56e0\u662f\u5176\u672a\u80fd\u7b26\u5408\u7b2c344\u53f7\u51b3\u7b56\u7684\u8981\u6c42\u3002<\/p><p><strong>2.\t\u4ec0\u4e48\u662f\u7b2c\u4e8c\u7528\u9014\u4e13\u5229\uff1f<\/strong><\/p><p>\u6839\u636e\u8d39\u5c14\u5357\u5fb7\u65af\u00b7\u8bfa\u6c83\u4e9a\u00b7\u74e6\u62c9\u8fbe\u96f7\u65af\u535a\u58eb\u7684\u8bf4\u6cd5\uff0c\u201c\u5236\u836f\u516c\u53f8\u8d8a\u6765\u8d8a\u591a\u5730\u5c06\u5176\u7814\u7a76\u6d3b\u52a8\u96c6\u4e2d\u5728\u4e3a\u5df2\u77e5\u5316\u5408\u7269\u53d1\u73b0\u65b0\u7684\u6cbb\u7597\u7528\u9014\u4e0a\u3002\u95ee\u9898\u5728\u4e8e\uff0c\u5982\u4f55\u4e3a\u8fd9\u7c7b\u53d1\u660e\u63d0\u4f9b\u4fdd\u62a4\uff0c\u8fd9\u4e9b\u53d1\u660e\u6d89\u53ca\u5df2\u7ecf\u77e5\u9053\u5177\u6709\u7279\u5b9a\u6cbb\u7597\u6d3b\u6027\u7684\u5316\u5408\u7269\uff0c\u5e76\u53d1\u73b0\u4e86\u4e00\u79cd\u4e0e\u5df2\u77e5\u7528\u9014\u65e0\u5173\u7684\u65b0\u7528\u9014\u3002\u201d<span>[1]<\/span><\/p><p>\u56e0\u6b64\uff0c\u7b2c\u4e8c\u7528\u9014\u4e13\u5229\u6307\u7684\u662f\u4ea7\u54c1\u6216\u5de5\u827a\u7684\u65b0\u7528\u9014\u3002\u5e38\u5e38\u53d1\u751f\u7684\u662f\uff0c\u5df2\u7ecf\u4e13\u5229\u7684\u4ea7\u54c1\u6216\u5de5\u827a\uff0c\u6216\u8005\u4ec5\u5177\u6709\u7279\u5b9a\u7528\u9014\u7684\u4ea7\u54c1\uff0c\u56e0\u5176\u672a\u6539\u53d8\u4e13\u5229\u6216\u672a\u4f7f\u5176\u6210\u4e3a\u65b0\u4e13\u5229\u800c\u88ab\u8d4b\u4e88\u5176\u4ed6\u7528\u9014\u3002<\/p><p><strong>3.\t\u7b2c\u4e8c\u7528\u9014\u4e13\u5229\u4e0e\u5236\u836f\u4ea7\u4e1a<\/strong><\/p><p>\u5982\u679c\u5141\u8bb8\u5bf9\u5df2\u77e5\u836f\u7269\u7684\u7b2c\u4e8c\u7528\u9014\u7533\u8bf7\u4e13\u5229\uff0c\u5219\u8be5\u4ea7\u54c1\u7684\u72ec\u5360\u6027\u53ef\u80fd\u4f1a\u8fdb\u4e00\u6b65\u5ef6\u4f38\u3002\u51fa\u4e8e\u5de5\u4e1a\u751f\u4ea7\u7684\u539f\u56e0\uff0c\u51e0\u4e4e\u4e0d\u53ef\u80fd\u5c06\u5df2\u8fc7\u671f\u4e13\u5229\u7684\u836f\u7269\u7684\u751f\u4ea7\u4e0e\u7528\u4e8e\u7b2c\u4e8c\u9002\u5e94\u75c7\u7684\u540c\u4e00\u836f\u7269\u751f\u4ea7\u5206\u5f00\uff0c\u540e\u8005\u7684\u4e13\u5229\u4ecd\u7136\u6709\u6548\u3002\u8fd9\u5c06\u5bfc\u81f4\u4ea7\u54c1\u7684\u72ec\u5360\u6027\u7531\u53d1\u660e\u5206\u5b50\u7684\u4eba\u7ef4\u6301\u3002<\/p><p>\u8fd9\u662f\u4e13\u5229\u6cd5\u4e2d\u7684\u4e00\u4e2a\u654f\u611f\u95ee\u9898\uff0c\u56e0\u4e3a\u5173\u4e8e\u7b2c\u4e8c\u7528\u9014\u4e13\u5229\u662f\u5426\u53ef\u4e13\u5229\u7684\u4e89\u8bba\u4ecd\u5728\u7ee7\u7eed\uff0c\u5c24\u5176\u662f\u56e0\u4e3a\u5b83\u4eec\u5bf9\u6240\u6709\u4eba\u5065\u5eb7\u83b7\u53d6\u6743\u7684\u91cd\u8981\u6027\uff0c\u4ee5\u53ca\u5728\u6cbb\u7597\u75be\u75c5\u4e2d\u7684\u4f5c\u7528\u3002<\/p><p>\u5173\u4e8e\u836f\u54c1\u4e13\u5229\uff0c\u300a\u4e0e\u8d38\u6613\u6709\u5173\u7684\u77e5\u8bc6\u4ea7\u6743\u534f\u8bae\u300b\uff08ADPIC\uff09\u89c4\u5b9a\u4e86\u4e09\u79cd\u901a\u7528\u4e49\u52a1\uff1a<\/p><ul style=\"padding: 0px 0px 0px 20px;\"><li>\u4e13\u5229\u6388\u4e88\uff0c\u65e0\u8bba\u662f\u4ea7\u54c1\u4e13\u5229\uff08\u4f8b\u5982\uff0c\u836f\u7269\uff09\u8fd8\u662f\u5de5\u827a\u4e13\u5229\uff08\u4f8b\u5982\uff0c\u751f\u4ea7\u836f\u7269\u5316\u5408\u7269\u7684\u65b9\u6cd5\uff09\uff0c\u5c3d\u7ba1\u6388\u4e88\u4ecd\u9700\u9075\u5b88ADPIC\u7b2c8\u6761\u3001\u7b2c3019\u6761\u3001\u7b2c3120\u6761\u548c\u7b2c4021\u6761\u89c4\u5b9a\u7684\u4f8b\u5916\uff1b<\/li><li>\u4e0d\u6b67\u89c6\uff0c\u8981\u6c42\u6210\u5458\u56fd\u5fc5\u987b\u6388\u4e88\u4e13\u5229\uff0c\u65e0\u8bba\u53d1\u660e\u6d89\u53ca\u7684\u6280\u672f\u9886\u57df\u5982\u4f55\u3002\u6362\u53e5\u8bdd\u8bf4\uff0c\u5236\u836f\u53d1\u660e\uff0c\u53ea\u8981\u6ee1\u8db3\u4e13\u5229\u8981\u6c42\uff08\u65b0\u9896\u6027\u3001\u521b\u9020\u6027\u548c\u5de5\u4e1a\u9002\u7528\u6027\uff09\uff0c\u5c06\u4e0e\u5176\u4ed6\u79d1\u5b66\u6280\u672f\u9886\u57df\u7684\u4e13\u5229\u53d1\u660e\u4e00\u6837\u53d7\u5230\u4fdd\u62a4\u3002\u6b67\u89c6\u4e5f\u4e0d\u80fd\u4ee5\u53d1\u660e\u7684\u6765\u6e90\u5730\u6216\u8be5\u53d1\u660e\u6240\u5728\u4ea7\u54c1\u662f\u8fdb\u53e3\u8fd8\u662f\u5728\u7279\u5b9a\u533a\u57df\u751f\u4ea7\u4e3a\u7406\u7531\uff1b<\/li><li>\u516c\u5f00\uff0c\u8981\u6c42\u786e\u4fdd\u53d1\u660e\u7684\u7ec6\u8282\u5728\u4e13\u5229\u7533\u8bf7\u4e2d\u5217\u51fa\uff0c\u4ee5\u4fbf\u5411\u516c\u4f17\u62ab\u9732\u3002\u6b64\u62ab\u9732\u4ea7\u54c1\u6216\u5de5\u827a\u4e13\u5229\u7684\u5177\u4f53\u8981\u6c42\uff0c\u751a\u81f3\u53ef\u80fd\u5bfc\u81f4\u63ed\u793a\u51fa\u518d\u73b0\u53d1\u660e\u6240\u9700\u7684\u6b65\u9aa4\u3002<span>[2]<\/span><\/li><\/ul><p>\u6b64\u5916\uff0c\u6211\u4eec\u5fc5\u987b\u6307\u51fa\uff0cADPIC\u7b2c27\u6761\u65e2\u4e0d\u63d0\u5021\u4e5f\u4e0d\u7981\u6b62\u7b2c\u4e8c\u7528\u9014\u4e13\u5229\uff0c\u56e0\u6b64\uff0c\u63a5\u53d7\u6216\u62d2\u7edd\u7b2c\u4e8c\u7528\u9014\u4e13\u5229\u7684WTO\u6210\u5458\u56fd\u7684\u4e13\u5229\u6cd5\u89c4\uff0c\u4e0d\u8fdd\u53cdADPIC\u3002<\/p><p><strong>4.\t\u793e\u533a\u89c4\u8303\u5728\u4f1f\u54e5\u6848\u4f8b\u4e2d\u7684\u4f18\u5148\u6027<\/strong><\/p><p>\u5b89\u7b2c\u65af\u5171\u540c\u4f53\u6cd5\u9662\u901a\u8fc789-AI-2000\u53f7\u6848\u4ef6\uff0c\u53d6\u6d88\u4e86\u7531INDECOPI\u6839\u636e1999\u5e741\u670829\u65e5\u7684\u7b2c000050\u53f7\u51b3\u8bae\u6388\u4e88\u8f89\u745e\u7684\u4e13\u5229\uff0c\u8be5\u4e13\u5229\u662f\u901a\u8fc7\u9002\u7528\u7b2c4\u6761\u300a\u6700\u9ad8\u6cd5\u4ee4010-97\/ITINC\u300b\u83b7\u5f97\u7684\uff0c\u8be5\u6cd5\u4ee4\u539f\u6587\u5982\u4e0b\uff1a<\/p><p>\u201c\u660e\u786e\u89c4\u5b9a\uff0c\u6839\u636e\u300a\u7b2c823\u53f7\u6cd5\u4ee4\u300b\u7b2c43\u6761\uff0c\u5982\u679c\u5728\u6280\u672f\u72b6\u6001\u4e2d\u5305\u542b\u7684\u7528\u9014\u4e0e\u539f\u59cb\u7528\u9014\u4e0d\u540c\uff0c\u5219\u82e5\u7b26\u5408\u300a\u7b2c823\u53f7\u6cd5\u4ee4\u300b\u7b2c22\u6761\u89c4\u5b9a\u7684\u6761\u4ef6\uff0c\u5c06\u4f5c\u4e3a\u65b0\u7684\u4e13\u5229\u8fdb\u884c\u6388\u4e88\u3002\u201d<\/p><p>\u867d\u7136\u6210\u5458\u56fd\u6709\u6743\u53d1\u5e03\u6cd5\u5f8b\u5de5\u5177\u4ee5\u9002\u5f53\u5b9e\u65bd\u300a\u7b2c344\u53f7\u51b3\u5b9a\u300b\uff0c\u4f46\u8fd9\u4e9b\u63aa\u65bd\u4e0d\u80fd\u5f15\u5165\u8fdd\u80cc\u5176\u7ed3\u6784\u7684\u4fee\u6539\u3002<\/p><p>\u5728\u672c\u6848\u4e2d\uff0c\u6cd5\u9662\u8ba4\u4e3a\u8be5\u6761\u6b3e\u626d\u66f2\u4e86\u5b89\u7b2c\u65af\u5171\u540c\u4f53\u5236\u5ea6\u7684\u539f\u5219\uff0c\u56e0\u4e3a\u5b83\u8fdd\u53cd\u4e86\u300a\u7b2c344\u53f7\u51b3\u5b9a\u300b\u7b2c16\u6761\u7684\u89c4\u5b9a\uff0c\u8be5\u6761\u6b3e\u660e\u786e\u7981\u6b62\u7b2c\u4e8c\u7528\u9014\u4e13\u5229\u3002\u6b64\u5916\uff0cINDECOPI\u672a\u80fd\u9075\u5b88\u79d8\u9c81\u4e0e\u5b89\u7b2c\u65af\u5171\u540c\u4f53\u8fbe\u6210\u7684\u627f\u8bfa\uff0c\u672a\u8003\u8651\u5230\u6cd5\u89c4\u7684\u5c42\u7ea7\uff0c\u9002\u7528\u4e86\u8f83\u4f4e\u5c42\u6b21\u7684\u6cd5\u89c4\uff0c<span>[3]<\/span>\u800c\u4e0d\u662f\u300a\u7b2c844\u53f7\u51b3\u5b9a\u300b\uff0c\u540e\u8005\u4ec5\u6b21\u4e8e\u6211\u4eec\u7684\u5baa\u6cd5\uff0c\u800c\u4e0d\u662f\u5176\u4ed6\u6cd5\u5f8b\uff0c\u56e0\u6b64\u6ca1\u6709\u4efb\u4f55\u56fd\u5185\u6cd5\u89c4\u53ef\u4ee5\u8fdd\u53cd\u5176\u4e2d\u7684\u89c4\u5b9a\u3002<\/p><p><strong>5.\t\u7ed3\u8bba<\/strong><\/p><p style=\"padding-left: 40px;\">\u7b2c\u4e8c\u7528\u9014\u4e13\u5229\u5728\u5b89\u7b2c\u65af\u5171\u540c\u4f53\u548c\u6211\u56fd\u88ab\u7981\u6b62\uff0c\u56e0\u4e3a\u5b83\u4eec\u5bf9\u6280\u672f\u8f6c\u8ba9\u548c\u5065\u5eb7\u83b7\u53d6\u6784\u6210\u4e86\u969c\u788d\u3002\u901a\u8fc7\u8fd9\u79cd\u7c7b\u578b\u7684\u4e13\u5229\uff0c\u76ee\u7684\u662f\u5ef6\u7eed\u5bf9\u5df2\u7ecf\u5c5e\u4e8e\u6280\u672f\u72b6\u6001\u7684\u836f\u54c1\u6216\u5de5\u827a\u7684\u5de5\u4e1a\u6743\u5229\uff0c\u8fd9\u66f4\u50cf\u662f\u4e00\u9879\u53d1\u73b0\uff0c\u800c\u4e0d\u662f\u4e00\u79cd\u771f\u6b63\u7684\u53d1\u660e\u3002<\/p><p style=\"padding-left: 40px;\">\u76ee\u524d\uff0c\u5728\u73b0\u884c\u7684\u300a\u7b2c486\u53f7\u51b3\u5b9a\u300b\u4e2d\uff0c\u4ecd\u7136\u4fdd\u6301\u5bf9\u7b2c\u4e8c\u7528\u9014\u4e13\u5229\u7684\u76f8\u540c\u7acb\u573a\uff0c\u5982\u7b2c21\u6761\u6240\u793a\uff1a<\/p><p style=\"padding-left: 40px;\">\u201c\u5df2\u7ecf\u4e13\u5229\u7684\u4ea7\u54c1\u6216\u5de5\u827a\uff0c\u6839\u636e\u672c\u51b3\u5b9a\u7b2c16\u6761\u7684\u89c4\u5b9a\uff0c\u82e5\u4ec5\u4ec5\u56e0\u4e3a\u8d4b\u4e88\u4e0d\u540c\u4e8e\u6700\u521d\u4e13\u5229\u7684\u7528\u9014\uff0c\u5c06\u4e0d\u518d\u6388\u4e88\u65b0\u7684\u4e13\u5229\u3002\u201d<\/p><p style=\"padding-left: 40px;\">\u540c\u65f6\uff0c\u5728\u300a\u7b2c1075\u53f7\u6cd5\u4ee4\u300b\u4e2d\uff0c\u5c3d\u7ba1\u6ca1\u6709\u660e\u786e\u7981\u6b62\u7b2c\u4e8c\u7528\u9014\u4e13\u5229\uff0c\u4e0e\u524d\u300a\u7b2c826\u53f7\u6cd5\u4ee4\u300b\u7b2c43\u6761\u7684\u660e\u786e\u89c4\u5b9a\u4e0d\u540c\uff0c\u4f46\u5176\u7b2c25\u6761\u7b2ca\u9879\u6307\u51fa\uff1a<\/p><p style=\"padding-left: 40px;\">\u201c\u4ee5\u4e0b\u4e0d\u89c6\u4e3a\u53d1\u660e\uff1a<\/p><p style=\"padding-left: 40px;\">\u53d1\u73b0\u3001\u79d1\u5b66\u7406\u8bba\u548c\u6570\u5b66\u65b9\u6cd5\u3002\u201d<\/p><p style=\"padding-left: 40px;\">\u8fd9\u8868\u660e\uff0c\u5c3d\u7ba1\u5168\u7403\u8d8b\u52bf\uff0c\u7279\u522b\u662f\u5728\u53d1\u8fbe\u56fd\u5bb6\u4e2d\uff0c\u503e\u5411\u4e8e\u6388\u4e88\u7b2c\u4e8c\u7528\u9014\u533b\u5b66\u53d1\u660e\u4e13\u5229\uff0c\u4f46\u5b89\u7b2c\u65af\u5171\u540c\u4f53\u59cb\u7ec8\u575a\u6301\u634d\u536b\u5176\u5229\u76ca\uff0c\u5e76\u672a\u5c48\u670d\u4e8e\u8de8\u56fd\u516c\u53f8\u548c\u5de5\u4e1a\u5316\u56fd\u5bb6\u7684\u538b\u529b\u3002<\/p><p>\u4f5c\u8005\uff1aJes\u00fas Cuba \/ Kelly S\u00e1nchez - \u77e5\u8bc6\u4ea7\u6743\u4e13\u5bb6<br \/>\u5f8b\u5e08\u4e8b\u52a1\u6240\uff1aOMC Abogados &amp; Consultores<\/p><p>___<\/p><p><span>[1]<\/span> FERNANDEZ NOVOA VALLADARES, Luis: \u4f5c\u54c1\u96c6\u300a\u836f\u54c1\u4e13\u5229\u7684\u53f8\u6cd5\u4fdd\u62a4\uff1a15\u5e74\u81f4\u529b\u4e8e\u521b\u65b0\u4fdd\u62a4\u300b \u7b2c37\u9875\uff0c\u897f\u73ed\u7259\u9a6c\u5fb7\u91cc\uff0c2002\u5e74\uff0c\u300a\u4fc3\u8fdb\u7814\u7a76\u7684\u7814\u7a76\u4e2d\u5fc3 \u2013 CEIFI\u300b\u3002<\/p><p><span>[2]<\/span> Rodr\u00edguez Spinelli, Francesca: \u201c\u7b2c\u4e8c\u7528\u9014\u4e13\u5229\uff1a\u6bd4\u8f83\u6cd5\u548c\u81ea\u7531\u8d38\u6613\u534f\u8bae\u4e2d\u7684\u65b0\u8d8b\u52bf\u201d \u8f7d\u4e8e\u300a\u77e5\u8bc6\u4ea7\u6743\u6742\u5fd7\u300b\u3002ISSN:1316-1164\u3002\u59d4\u5185\u745e\u62c9\u7f8e\u4e3d\u8fbe\u3002\u7b2c\u5341\u5e74\uff0c\u7b2c14\u671f\uff0c2011\u5e741\u6708\u81f312\u6708\uff0c\u9875127\u3002<\/p><p><span>[3]<\/span> \u52a0\u5c14\u5854\u8d6b\u7eb3\u534f\u8bae\uff0c1969\u5e745\u670826\u65e5\u8d77\u6210\u4e3a\u6210\u5458\u56fd\u3002<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c8fe210 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"c8fe210\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9b2c533 elementor-widget elementor-widget-text-editor\" data-id=\"9b2c533\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>\u672c\u6587\u4e5f\u5df2\u53d1\u5e03\u5728\u4ee5\u4e0b\u7f51\u7ad9\uff1a<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-16df1a0 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"16df1a0\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-25 elementor-top-column elementor-element elementor-element-9d7824f\" data-id=\"9d7824f\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-bd6beb0 elementor-widget elementor-widget-image\" data-id=\"bd6beb0\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/second-use-patents-the-viagra-case-in-peru-the-patent-lawyer-julio-2016.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"150\" src=\"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medio-the-patent-lawyer.jpg\" class=\"attachment-medium size-medium wp-image-5476\" alt=\"\" title=\"medio-the-patent-lawyer\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element-custom_font_size elementor-element elementor-element-821d878 elementor-widget elementor-widget-text-editor\" data-id=\"821d878\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">2016\u5e747\u6708<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-25 elementor-top-column elementor-element elementor-element-6311517\" data-id=\"6311517\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-179d170 elementor-widget elementor-widget-image\" data-id=\"179d170\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/second-use-patents-the-viagra-case-in-peru-ippropatents-marzo2017.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"150\" src=\"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medio-ip-pro-patents.png\" class=\"attachment-medium size-medium wp-image-5449\" alt=\"\" title=\"medio-ip-pro-patents\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element-custom_font_size elementor-element elementor-element-ef4fadd elementor-widget elementor-widget-text-editor\" data-id=\"ef4fadd\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">2017\u5e743\u6708<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-25 elementor-top-column elementor-element elementor-element-74c972f\" data-id=\"74c972f\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-25 elementor-top-column elementor-element elementor-element-13a4cff\" data-id=\"13a4cff\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>1. Antecedentes: En Mayo de 1994, Pfizer solicit\u00f3 para uso m\u00e9dico la patente denominada \u201cPirazolopirimidinona para el tratamiento de la impotencia\u00bb, m\u00e1s conocida como Viagra, cuyo compuesto qu\u00edmico el \u201ccitrato de sildenafil\u201d ya era usado para el tratamiento de enfermedades cardiovasculares. La solicitud hab\u00eda sido rechazada hasta en 3 ocasiones anteriores por la Oficina de [&hellip;]<\/p>","protected":false},"author":1,"featured_media":14777,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_vp_format_video_url":"","_vp_image_focal_point":[],"_vp_custom_popup_image":0,"_vp_format_audio_url":"","_vp_custom_thumbnail":0,"_vp_custom_thumbnail_focal_point":[],"_vp_hover_thumbnail":0,"_vp_hover_thumbnail_focal_point":[],"footnotes":""},"categories":[46],"tags":[],"class_list":["post-5472","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articulos"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Las patentes de segundo uso: El caso Viagra en el Per\u00fa - OMC Abogados &amp; Consultores<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/omcabogados.com.pe\/zh\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Las patentes de segundo uso: El caso Viagra en el Per\u00fa - OMC Abogados &amp; Consultores\" \/>\n<meta property=\"og:description\" content=\"1. Antecedentes: En Mayo de 1994, Pfizer solicit\u00f3 para uso m\u00e9dico la patente denominada \u201cPirazolopirimidinona para el tratamiento de la impotencia\u00bb, m\u00e1s conocida como Viagra, cuyo compuesto qu\u00edmico el \u201ccitrato de sildenafil\u201d ya era usado para el tratamiento de enfermedades cardiovasculares. La solicitud hab\u00eda sido rechazada hasta en 3 ocasiones anteriores por la Oficina de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/omcabogados.com.pe\/zh\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/\" \/>\n<meta property=\"og:site_name\" content=\"OMC Abogados &amp; Consultores\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/omcabogados.consultores\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-07-03T00:49:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-12T16:11:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"228\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"WebMasterOMC\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@omcabogadosperu\" \/>\n<meta name=\"twitter:site\" content=\"@omcabogadosperu\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"WebMasterOMC\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/\"},\"author\":{\"name\":\"WebMasterOMC\",\"@id\":\"https:\/\/omcabogados.com.pe\/es\/#\/schema\/person\/5631656d9b6382d013b99eae0095efa6\"},\"headline\":\"Las patentes de segundo uso: El caso Viagra en el Per\u00fa\",\"datePublished\":\"2016-07-03T00:49:02+00:00\",\"dateModified\":\"2025-08-12T16:11:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/\"},\"wordCount\":1766,\"publisher\":{\"@id\":\"https:\/\/omcabogados.com.pe\/es\/#organization\"},\"image\":{\"@id\":\"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg\",\"articleSection\":[\"Art\u00edculos\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/\",\"url\":\"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/\",\"name\":\"Las patentes de segundo uso: El caso Viagra en el Per\u00fa - OMC Abogados &amp; Consultores\",\"isPartOf\":{\"@id\":\"https:\/\/omcabogados.com.pe\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg\",\"datePublished\":\"2016-07-03T00:49:02+00:00\",\"dateModified\":\"2025-08-12T16:11:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/#primaryimage\",\"url\":\"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg\",\"contentUrl\":\"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg\",\"width\":300,\"height\":228},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/omcabogados.com.pe\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Las patentes de segundo uso: El caso Viagra en el Per\u00fa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/omcabogados.com.pe\/es\/#website\",\"url\":\"https:\/\/omcabogados.com.pe\/es\/\",\"name\":\"OMC Abogados & Consultores\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/omcabogados.com.pe\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/omcabogados.com.pe\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/omcabogados.com.pe\/es\/#organization\",\"name\":\"OMC Abogados & Consultores\",\"url\":\"https:\/\/omcabogados.com.pe\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/omcabogados.com.pe\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/logo-omc-abogados.png\",\"contentUrl\":\"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/logo-omc-abogados.png\",\"width\":210,\"height\":159,\"caption\":\"OMC Abogados & Consultores\"},\"image\":{\"@id\":\"https:\/\/omcabogados.com.pe\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/omcabogados.consultores\/\",\"https:\/\/x.com\/omcabogadosperu\",\"https:\/\/www.linkedin.com\/company\/omc-abogados-consultores\/?viewAsMember=true\",\"https:\/\/www.instagram.com\/omcabogadosyconsultores\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/omcabogados.com.pe\/es\/#\/schema\/person\/5631656d9b6382d013b99eae0095efa6\",\"name\":\"WebMasterOMC\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/omcabogados.com.pe\/es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/391a7241c813c901b966c257e8cb1f77990418d26f69214d049a227c5aa23c44?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/391a7241c813c901b966c257e8cb1f77990418d26f69214d049a227c5aa23c44?s=96&d=mm&r=g\",\"caption\":\"WebMasterOMC\"},\"sameAs\":[\"https:\/\/omcabogados.com.pe\"],\"url\":\"https:\/\/omcabogados.com.pe\/zh\/author\/webmasteromc\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Las patentes de segundo uso: El caso Viagra en el Per\u00fa - OMC Abogados &amp; Consultores","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/omcabogados.com.pe\/zh\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/","og_locale":"zh_CN","og_type":"article","og_title":"Las patentes de segundo uso: El caso Viagra en el Per\u00fa - OMC Abogados &amp; Consultores","og_description":"1. Antecedentes: En Mayo de 1994, Pfizer solicit\u00f3 para uso m\u00e9dico la patente denominada \u201cPirazolopirimidinona para el tratamiento de la impotencia\u00bb, m\u00e1s conocida como Viagra, cuyo compuesto qu\u00edmico el \u201ccitrato de sildenafil\u201d ya era usado para el tratamiento de enfermedades cardiovasculares. La solicitud hab\u00eda sido rechazada hasta en 3 ocasiones anteriores por la Oficina de [&hellip;]","og_url":"https:\/\/omcabogados.com.pe\/zh\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/","og_site_name":"OMC Abogados &amp; Consultores","article_publisher":"https:\/\/www.facebook.com\/omcabogados.consultores\/","article_published_time":"2016-07-03T00:49:02+00:00","article_modified_time":"2025-08-12T16:11:28+00:00","og_image":[{"width":300,"height":228,"url":"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg","type":"image\/jpeg"}],"author":"WebMasterOMC","twitter_card":"summary_large_image","twitter_creator":"@omcabogadosperu","twitter_site":"@omcabogadosperu","twitter_misc":{"\u4f5c\u8005":"WebMasterOMC","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"8 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/#article","isPartOf":{"@id":"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/"},"author":{"name":"WebMasterOMC","@id":"https:\/\/omcabogados.com.pe\/es\/#\/schema\/person\/5631656d9b6382d013b99eae0095efa6"},"headline":"Las patentes de segundo uso: El caso Viagra en el Per\u00fa","datePublished":"2016-07-03T00:49:02+00:00","dateModified":"2025-08-12T16:11:28+00:00","mainEntityOfPage":{"@id":"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/"},"wordCount":1766,"publisher":{"@id":"https:\/\/omcabogados.com.pe\/es\/#organization"},"image":{"@id":"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/#primaryimage"},"thumbnailUrl":"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg","articleSection":["Art\u00edculos"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/","url":"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/","name":"Las patentes de segundo uso: El caso Viagra en el Per\u00fa - OMC Abogados &amp; Consultores","isPartOf":{"@id":"https:\/\/omcabogados.com.pe\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/#primaryimage"},"image":{"@id":"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/#primaryimage"},"thumbnailUrl":"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg","datePublished":"2016-07-03T00:49:02+00:00","dateModified":"2025-08-12T16:11:28+00:00","breadcrumb":{"@id":"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/#primaryimage","url":"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg","contentUrl":"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg","width":300,"height":228},{"@type":"BreadcrumbList","@id":"https:\/\/omcabogados.com.pe\/es\/las-patentes-de-segundo-uso-el-caso-viagra-en-el-peru\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/omcabogados.com.pe\/"},{"@type":"ListItem","position":2,"name":"Las patentes de segundo uso: El caso Viagra en el Per\u00fa"}]},{"@type":"WebSite","@id":"https:\/\/omcabogados.com.pe\/es\/#website","url":"https:\/\/omcabogados.com.pe\/es\/","name":"OMC Abogados & Consultores","description":"","publisher":{"@id":"https:\/\/omcabogados.com.pe\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/omcabogados.com.pe\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/omcabogados.com.pe\/es\/#organization","name":"OMC Abogados & Consultores","url":"https:\/\/omcabogados.com.pe\/es\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/omcabogados.com.pe\/es\/#\/schema\/logo\/image\/","url":"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/logo-omc-abogados.png","contentUrl":"https:\/\/omcabogados.com.pe\/wp-content\/uploads\/logo-omc-abogados.png","width":210,"height":159,"caption":"OMC Abogados & Consultores"},"image":{"@id":"https:\/\/omcabogados.com.pe\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/omcabogados.consultores\/","https:\/\/x.com\/omcabogadosperu","https:\/\/www.linkedin.com\/company\/omc-abogados-consultores\/?viewAsMember=true","https:\/\/www.instagram.com\/omcabogadosyconsultores\/"]},{"@type":"Person","@id":"https:\/\/omcabogados.com.pe\/es\/#\/schema\/person\/5631656d9b6382d013b99eae0095efa6","name":"WebMasterOMC","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/omcabogados.com.pe\/es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/391a7241c813c901b966c257e8cb1f77990418d26f69214d049a227c5aa23c44?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/391a7241c813c901b966c257e8cb1f77990418d26f69214d049a227c5aa23c44?s=96&d=mm&r=g","caption":"WebMasterOMC"},"sameAs":["https:\/\/omcabogados.com.pe"],"url":"https:\/\/omcabogados.com.pe\/zh\/author\/webmasteromc\/"}]}},"rttpg_featured_image_url":{"full":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false],"landscape":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false],"portraits":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false],"thumbnail":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados-300x170.jpg",300,170,true],"medium":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false],"large":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false],"1536x1536":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false],"2048x2048":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false],"trp-custom-language-flag":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados-16x12.jpg",16,12,true],"gt3theme_mobile":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false],"vp_sm":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false],"vp_md":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false],"vp_lg":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false],"vp_xl":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false],"vp_sm_popup":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false],"vp_md_popup":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false],"vp_xl_popup":["https:\/\/omcabogados.com.pe\/wp-content\/uploads\/medios-omc-abogados.jpg",300,228,false]},"rttpg_author":{"display_name":"WebMasterOMC","author_link":"https:\/\/omcabogados.com.pe\/zh\/author\/webmasteromc\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/omcabogados.com.pe\/zh\/category\/prensa\/articulos\/\" rel=\"category tag\">Art\u00edculos<\/a>","rttpg_excerpt":"1. Antecedentes: En Mayo de 1994, Pfizer solicit\u00f3 para uso m\u00e9dico la patente denominada \u201cPirazolopirimidinona para el tratamiento de la impotencia\u00bb, m\u00e1s conocida como Viagra, cuyo compuesto qu\u00edmico el \u201ccitrato de sildenafil\u201d ya era usado para el tratamiento de enfermedades cardiovasculares. La solicitud hab\u00eda sido rechazada hasta en 3 ocasiones anteriores por la Oficina de&hellip;","_links":{"self":[{"href":"https:\/\/omcabogados.com.pe\/zh\/wp-json\/wp\/v2\/posts\/5472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/omcabogados.com.pe\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/omcabogados.com.pe\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/omcabogados.com.pe\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/omcabogados.com.pe\/zh\/wp-json\/wp\/v2\/comments?post=5472"}],"version-history":[{"count":40,"href":"https:\/\/omcabogados.com.pe\/zh\/wp-json\/wp\/v2\/posts\/5472\/revisions"}],"predecessor-version":[{"id":16197,"href":"https:\/\/omcabogados.com.pe\/zh\/wp-json\/wp\/v2\/posts\/5472\/revisions\/16197"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/omcabogados.com.pe\/zh\/wp-json\/wp\/v2\/media\/14777"}],"wp:attachment":[{"href":"https:\/\/omcabogados.com.pe\/zh\/wp-json\/wp\/v2\/media?parent=5472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/omcabogados.com.pe\/zh\/wp-json\/wp\/v2\/categories?post=5472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/omcabogados.com.pe\/zh\/wp-json\/wp\/v2\/tags?post=5472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}